← Open Payments lookup

WINGNAY CHERNESKY: Open Payments

NPI 1437830619 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,469 in 98 payments from 22 companies in 2025. Trend: 2023 $697 · 2024 $1,495 · 2025 $2,469

Food & beverage: $2,385Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.13$348
Madrigal Pharmaceuticals9$337
GENZYME CORPORATION8$301
Ardelyx, Inc.13$291
Takeda Pharmaceuticals U.S.A., Inc.9$264
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$146
ABBVIE INC.6$120
Aimmune Therapeutics, Inc.4$110
PFIZER INC.6$101
Lilly USA, LLC3$89

Products named: TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, ENTYVIO, XIFAXAN, VOWST, OMVOH.

Industry payments across MD — which companies pay providers there.